Impact of Bleeding and Bivalirudin Therapy on Mortality Risk in Women Undergoing Percutaneous Coronary Intervention (from the REPLACE-2, ACUITY, and HORIZONS-AMI Trials)-Reference-Cited by-同舟云学术

Impact of Bleeding and Bivalirudin Therapy on Mortality Risk in Women Undergoing Percutaneous Coronary Intervention (from the REPLACE-2, ACUITY, and HORIZONS-AMI Trials)

Published:2016-01 Issue:2 Volume:117 Page:186-191
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Ng Vivian G.,Baumbach Andreas,Grinfeld Liliana,Lincoff A. Michael,Mehran Roxana,Stone Gregg W.,Lansky Alexandra J.^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Comparison of baseline characteristics, clinical features, angiographic results, and early outcomes in men vs women with acute myocardial infarction undergoing primary coronary intervention;Cheng;Chest,2004

2. Sex differences in outcomes after cardiac catheterization: effect modification by treatment strategy and time;King;JAMA,2004

3. Sex-based differences in early mortality of patients undergoing primary angioplasty for first acute myocardial infarction;Vakili;Circulation,2001

4. Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20,290 patients from the AMIS Plus Registry;Radovanovic;Heart,2007

5. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE);Moscucci;Eur Heart J,2003

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bivalirudin versus heparin in STEMI after BRIGHT-4 trial: an updated meta-analysis;Coronary Artery Disease;2023-09-20

2. Sex Differences in Therapies against Myocardial Ischemia-Reperfusion Injury: From Basic Science to Clinical Perspectives;Cells;2023-08-16

3. Bivalirudin versus Heparin on Net Adverse Clinical Events, Major Adverse Cardiac and Cerebral Events, and Bleeding in Elderly Chinese Patients Treated with Percutaneous Coronary Intervention;The Tohoku Journal of Experimental Medicine;2023

4. Bivalirudin Use for Primary Percutaneous Coronary Intervention on Long-Term Mortality;Journal of Cardiovascular Pharmacology;2021-07

5. Sex Differences in Acute Bleeding and Vascular Complications Following Percutaneous Coronary Intervention Between 2003 and 2016: Trends From the Dartmouth Dynamic Registry;Cardiovascular Revascularization Medicine;2021-07